nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—blood vessel—stomach cancer	0.0153	0.0791	CbGeAlD
Danazol—CCL2—gall bladder—stomach cancer	0.0144	0.0744	CbGeAlD
Danazol—CCL2—hematopoietic system—stomach cancer	0.00813	0.0421	CbGeAlD
Danazol—PGR—blood vessel—stomach cancer	0.00802	0.0415	CbGeAlD
Danazol—CCL2—epithelium—stomach cancer	0.00743	0.0385	CbGeAlD
Danazol—CCL2—smooth muscle tissue—stomach cancer	0.00716	0.0371	CbGeAlD
Danazol—CCL2—pancreas—stomach cancer	0.00662	0.0343	CbGeAlD
Danazol—ESR1—blood vessel—stomach cancer	0.00628	0.0325	CbGeAlD
Danazol—GNRHR—endocrine gland—stomach cancer	0.00598	0.031	CbGeAlD
Danazol—CCL2—lymphoid tissue—stomach cancer	0.00572	0.0296	CbGeAlD
Danazol—CCL2—digestive system—stomach cancer	0.00565	0.0293	CbGeAlD
Danazol—CCL2—bone marrow—stomach cancer	0.00521	0.027	CbGeAlD
Danazol—SHBG—hematopoietic system—stomach cancer	0.00474	0.0246	CbGeAlD
Danazol—CCL2—endocrine gland—stomach cancer	0.00467	0.0242	CbGeAlD
Danazol—PGR—hematopoietic system—stomach cancer	0.00427	0.0221	CbGeAlD
Danazol—CCL2—liver—stomach cancer	0.00421	0.0218	CbGeAlD
Danazol—PGR—epithelium—stomach cancer	0.00391	0.0202	CbGeAlD
Danazol—CYP19A1—hematopoietic system—stomach cancer	0.00384	0.0199	CbGeAlD
Danazol—PGR—smooth muscle tissue—stomach cancer	0.00376	0.0195	CbGeAlD
Danazol—AR—hematopoietic system—stomach cancer	0.0034	0.0176	CbGeAlD
Danazol—ESR1—hematopoietic system—stomach cancer	0.00334	0.0173	CbGeAlD
Danazol—CCL2—lymph node—stomach cancer	0.00323	0.0167	CbGeAlD
Danazol—AR—epithelium—stomach cancer	0.00311	0.0161	CbGeAlD
Danazol—ESR1—epithelium—stomach cancer	0.00305	0.0158	CbGeAlD
Danazol—SHBG—bone marrow—stomach cancer	0.00304	0.0157	CbGeAlD
Danazol—PGR—lymphoid tissue—stomach cancer	0.00301	0.0156	CbGeAlD
Danazol—AR—smooth muscle tissue—stomach cancer	0.003	0.0155	CbGeAlD
Danazol—ESR1—smooth muscle tissue—stomach cancer	0.00294	0.0152	CbGeAlD
Danazol—SHBG—endocrine gland—stomach cancer	0.00273	0.0141	CbGeAlD
Danazol—SHBG—liver—stomach cancer	0.00246	0.0127	CbGeAlD
Danazol—PGR—endocrine gland—stomach cancer	0.00246	0.0127	CbGeAlD
Danazol—AR—lymphoid tissue—stomach cancer	0.0024	0.0124	CbGeAlD
Danazol—AR—digestive system—stomach cancer	0.00237	0.0123	CbGeAlD
Danazol—ESR1—lymphoid tissue—stomach cancer	0.00235	0.0122	CbGeAlD
Danazol—ESR1—digestive system—stomach cancer	0.00232	0.012	CbGeAlD
Danazol—CYP19A1—endocrine gland—stomach cancer	0.00221	0.0114	CbGeAlD
Danazol—CYP19A1—liver—stomach cancer	0.00199	0.0103	CbGeAlD
Danazol—AR—endocrine gland—stomach cancer	0.00196	0.0101	CbGeAlD
Danazol—ESR1—endocrine gland—stomach cancer	0.00192	0.00994	CbGeAlD
Danazol—CYP3A4—hematopoietic system—stomach cancer	0.00186	0.00965	CbGeAlD
Danazol—AR—liver—stomach cancer	0.00176	0.00913	CbGeAlD
Danazol—ESR1—liver—stomach cancer	0.00173	0.00896	CbGeAlD
Danazol—PGR—lymph node—stomach cancer	0.0017	0.00879	CbGeAlD
Danazol—Hydrocortisone—ANXA1—stomach cancer	0.00153	0.544	CrCbGaD
Danazol—CYP19A1—lymph node—stomach cancer	0.00153	0.00791	CbGeAlD
Danazol—AR—lymph node—stomach cancer	0.00135	0.007	CbGeAlD
Danazol—ESR1—lymph node—stomach cancer	0.00133	0.00687	CbGeAlD
Danazol—CYP3A4—digestive system—stomach cancer	0.0013	0.00671	CbGeAlD
Danazol—CYP3A4—endocrine gland—stomach cancer	0.00107	0.00555	CbGeAlD
Danazol—CYP3A4—liver—stomach cancer	0.000966	0.005	CbGeAlD
Danazol—Convulsion—Fluorouracil—stomach cancer	0.000749	0.00208	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00074	0.00206	CcSEcCtD
Danazol—Haematuria—Capecitabine—stomach cancer	0.000737	0.00205	CcSEcCtD
Danazol—Oedema—Irinotecan—stomach cancer	0.000736	0.00205	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—stomach cancer	0.000736	0.00205	CcSEcCtD
Danazol—Shock—Irinotecan—stomach cancer	0.000725	0.00201	CcSEcCtD
Danazol—Thrombocytopenia—Irinotecan—stomach cancer	0.000721	0.00201	CcSEcCtD
Danazol—Haemoglobin—Docetaxel—stomach cancer	0.00072	0.002	CcSEcCtD
Danazol—Haemorrhage—Docetaxel—stomach cancer	0.000717	0.00199	CcSEcCtD
Danazol—Irritability—Methotrexate—stomach cancer	0.000713	0.00198	CcSEcCtD
Danazol—Hyperhidrosis—Irinotecan—stomach cancer	0.000712	0.00198	CcSEcCtD
Danazol—Mood swings—Methotrexate—stomach cancer	0.000707	0.00197	CcSEcCtD
Danazol—Oedema—Fluorouracil—stomach cancer	0.000705	0.00196	CcSEcCtD
Danazol—Haemoglobin—Capecitabine—stomach cancer	0.000697	0.00194	CcSEcCtD
Danazol—Haemorrhage—Capecitabine—stomach cancer	0.000694	0.00193	CcSEcCtD
Danazol—Thrombocytopenia—Fluorouracil—stomach cancer	0.000691	0.00192	CcSEcCtD
Danazol—Visual impairment—Docetaxel—stomach cancer	0.000691	0.00192	CcSEcCtD
Danazol—Tachycardia—Fluorouracil—stomach cancer	0.000688	0.00191	CcSEcCtD
Danazol—Affect lability—Epirubicin—stomach cancer	0.000688	0.00191	CcSEcCtD
Danazol—Migraine—Epirubicin—stomach cancer	0.000688	0.00191	CcSEcCtD
Danazol—Erythema multiforme—Docetaxel—stomach cancer	0.000677	0.00188	CcSEcCtD
Danazol—Visual impairment—Capecitabine—stomach cancer	0.000669	0.00186	CcSEcCtD
Danazol—Flushing—Docetaxel—stomach cancer	0.000665	0.00185	CcSEcCtD
Danazol—Mood swings—Epirubicin—stomach cancer	0.000662	0.00184	CcSEcCtD
Danazol—Paraesthesia—Irinotecan—stomach cancer	0.000661	0.00184	CcSEcCtD
Danazol—Erythema multiforme—Capecitabine—stomach cancer	0.000656	0.00182	CcSEcCtD
Danazol—Dyspepsia—Irinotecan—stomach cancer	0.000648	0.0018	CcSEcCtD
Danazol—Flushing—Capecitabine—stomach cancer	0.000644	0.00179	CcSEcCtD
Danazol—Chills—Docetaxel—stomach cancer	0.000643	0.00179	CcSEcCtD
Danazol—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000643	0.00179	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—stomach cancer	0.000639	0.00178	CcSEcCtD
Danazol—Abdominal pain upper—Epirubicin—stomach cancer	0.000638	0.00177	CcSEcCtD
Danazol—Affect lability—Doxorubicin—stomach cancer	0.000636	0.00177	CcSEcCtD
Danazol—Migraine—Doxorubicin—stomach cancer	0.000636	0.00177	CcSEcCtD
Danazol—Fatigue—Irinotecan—stomach cancer	0.000635	0.00177	CcSEcCtD
Danazol—Paraesthesia—Fluorouracil—stomach cancer	0.000633	0.00176	CcSEcCtD
Danazol—Alopecia—Docetaxel—stomach cancer	0.000633	0.00176	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—stomach cancer	0.000633	0.00176	CcSEcCtD
Danazol—Constipation—Irinotecan—stomach cancer	0.00063	0.00175	CcSEcCtD
Danazol—Chills—Capecitabine—stomach cancer	0.000622	0.00173	CcSEcCtD
Danazol—Dyspepsia—Fluorouracil—stomach cancer	0.000621	0.00173	CcSEcCtD
Danazol—Alopecia—Capecitabine—stomach cancer	0.000613	0.0017	CcSEcCtD
Danazol—Mood swings—Doxorubicin—stomach cancer	0.000612	0.0017	CcSEcCtD
Danazol—Back pain—Docetaxel—stomach cancer	0.000603	0.00168	CcSEcCtD
Danazol—Muscle spasms—Docetaxel—stomach cancer	0.0006	0.00167	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—stomach cancer	0.000598	0.00166	CcSEcCtD
Danazol—Pancreatitis—Epirubicin—stomach cancer	0.000592	0.00165	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—stomach cancer	0.00059	0.00164	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—stomach cancer	0.000589	0.00164	CcSEcCtD
Danazol—Back pain—Capecitabine—stomach cancer	0.000584	0.00162	CcSEcCtD
Danazol—Body temperature increased—Irinotecan—stomach cancer	0.000582	0.00162	CcSEcCtD
Danazol—Muscle spasms—Capecitabine—stomach cancer	0.000581	0.00161	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00057	0.00159	CcSEcCtD
Danazol—Vision blurred—Capecitabine—stomach cancer	0.000569	0.00158	CcSEcCtD
Danazol—Tremor—Capecitabine—stomach cancer	0.000566	0.00157	CcSEcCtD
Danazol—Urticaria—Fluorouracil—stomach cancer	0.00056	0.00156	CcSEcCtD
Danazol—Syncope—Docetaxel—stomach cancer	0.000559	0.00156	CcSEcCtD
Danazol—Leukopenia—Docetaxel—stomach cancer	0.000558	0.00155	CcSEcCtD
Danazol—Body temperature increased—Fluorouracil—stomach cancer	0.000558	0.00155	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—stomach cancer	0.000553	0.00154	CcSEcCtD
Danazol—Sweating—Methotrexate—stomach cancer	0.000552	0.00153	CcSEcCtD
Danazol—Palpitations—Docetaxel—stomach cancer	0.000551	0.00153	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—stomach cancer	0.000551	0.00153	CcSEcCtD
Danazol—Weight increased—Epirubicin—stomach cancer	0.00055	0.00153	CcSEcCtD
Danazol—Haematuria—Methotrexate—stomach cancer	0.000549	0.00153	CcSEcCtD
Danazol—Loss of consciousness—Docetaxel—stomach cancer	0.000548	0.00152	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—stomach cancer	0.000548	0.00152	CcSEcCtD
Danazol—Vertigo—Capecitabine—stomach cancer	0.000543	0.00151	CcSEcCtD
Danazol—Syncope—Capecitabine—stomach cancer	0.000542	0.00151	CcSEcCtD
Danazol—Leukopenia—Capecitabine—stomach cancer	0.000541	0.0015	CcSEcCtD
Danazol—Convulsion—Docetaxel—stomach cancer	0.00054	0.0015	CcSEcCtD
Danazol—Hypertension—Docetaxel—stomach cancer	0.000539	0.0015	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000534	0.00148	CcSEcCtD
Danazol—Palpitations—Capecitabine—stomach cancer	0.000534	0.00148	CcSEcCtD
Danazol—Arthralgia—Docetaxel—stomach cancer	0.000531	0.00148	CcSEcCtD
Danazol—Loss of consciousness—Capecitabine—stomach cancer	0.000531	0.00148	CcSEcCtD
Danazol—Asthenia—Irinotecan—stomach cancer	0.000528	0.00147	CcSEcCtD
Danazol—Jaundice—Epirubicin—stomach cancer	0.000525	0.00146	CcSEcCtD
Danazol—Hypertension—Capecitabine—stomach cancer	0.000521	0.00145	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—stomach cancer	0.000519	0.00144	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—stomach cancer	0.000516	0.00144	CcSEcCtD
Danazol—Sweating—Epirubicin—stomach cancer	0.000516	0.00144	CcSEcCtD
Danazol—Arthralgia—Capecitabine—stomach cancer	0.000514	0.00143	CcSEcCtD
Danazol—Haematuria—Epirubicin—stomach cancer	0.000513	0.00143	CcSEcCtD
Danazol—Anxiety—Capecitabine—stomach cancer	0.000512	0.00142	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00051	0.00142	CcSEcCtD
Danazol—Oedema—Docetaxel—stomach cancer	0.000509	0.00142	CcSEcCtD
Danazol—Weight increased—Doxorubicin—stomach cancer	0.000508	0.00141	CcSEcCtD
Danazol—Shock—Docetaxel—stomach cancer	0.000501	0.00139	CcSEcCtD
Danazol—Pruritus—Fluorouracil—stomach cancer	0.000499	0.00139	CcSEcCtD
Danazol—Thrombocytopenia—Docetaxel—stomach cancer	0.000498	0.00139	CcSEcCtD
Danazol—Visual impairment—Methotrexate—stomach cancer	0.000498	0.00138	CcSEcCtD
Danazol—Tachycardia—Docetaxel—stomach cancer	0.000497	0.00138	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000494	0.00137	CcSEcCtD
Danazol—Oedema—Capecitabine—stomach cancer	0.000493	0.00137	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—stomach cancer	0.000488	0.00136	CcSEcCtD
Danazol—Dizziness—Irinotecan—stomach cancer	0.000487	0.00135	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—stomach cancer	0.000486	0.00135	CcSEcCtD
Danazol—Jaundice—Doxorubicin—stomach cancer	0.000486	0.00135	CcSEcCtD
Danazol—Shock—Capecitabine—stomach cancer	0.000485	0.00135	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—stomach cancer	0.000483	0.00134	CcSEcCtD
Danazol—Thrombocytopenia—Capecitabine—stomach cancer	0.000483	0.00134	CcSEcCtD
Danazol—Tachycardia—Capecitabine—stomach cancer	0.000481	0.00134	CcSEcCtD
Danazol—Sweating—Doxorubicin—stomach cancer	0.000478	0.00133	CcSEcCtD
Danazol—Hyperhidrosis—Capecitabine—stomach cancer	0.000476	0.00133	CcSEcCtD
Danazol—Haematuria—Doxorubicin—stomach cancer	0.000475	0.00132	CcSEcCtD
Danazol—Vomiting—Irinotecan—stomach cancer	0.000468	0.0013	CcSEcCtD
Danazol—Dizziness—Fluorouracil—stomach cancer	0.000466	0.0013	CcSEcCtD
Danazol—Visual impairment—Epirubicin—stomach cancer	0.000466	0.0013	CcSEcCtD
Danazol—Rash—Irinotecan—stomach cancer	0.000464	0.00129	CcSEcCtD
Danazol—Dermatitis—Irinotecan—stomach cancer	0.000464	0.00129	CcSEcCtD
Danazol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000464	0.00129	CcSEcCtD
Danazol—Chills—Methotrexate—stomach cancer	0.000463	0.00129	CcSEcCtD
Danazol—Headache—Irinotecan—stomach cancer	0.000461	0.00128	CcSEcCtD
Danazol—Paraesthesia—Docetaxel—stomach cancer	0.000457	0.00127	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—stomach cancer	0.000457	0.00127	CcSEcCtD
Danazol—Alopecia—Methotrexate—stomach cancer	0.000456	0.00127	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—stomach cancer	0.000449	0.00125	CcSEcCtD
Danazol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000449	0.00125	CcSEcCtD
Danazol—Flushing—Epirubicin—stomach cancer	0.000449	0.00125	CcSEcCtD
Danazol—Vomiting—Fluorouracil—stomach cancer	0.000448	0.00125	CcSEcCtD
Danazol—Dyspepsia—Docetaxel—stomach cancer	0.000448	0.00125	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—stomach cancer	0.000447	0.00124	CcSEcCtD
Danazol—Rash—Fluorouracil—stomach cancer	0.000445	0.00124	CcSEcCtD
Danazol—Dermatitis—Fluorouracil—stomach cancer	0.000444	0.00124	CcSEcCtD
Danazol—Paraesthesia—Capecitabine—stomach cancer	0.000443	0.00123	CcSEcCtD
Danazol—Headache—Fluorouracil—stomach cancer	0.000442	0.00123	CcSEcCtD
Danazol—Fatigue—Docetaxel—stomach cancer	0.000439	0.00122	CcSEcCtD
Danazol—Nausea—Irinotecan—stomach cancer	0.000437	0.00122	CcSEcCtD
Danazol—Constipation—Docetaxel—stomach cancer	0.000435	0.00121	CcSEcCtD
Danazol—Back pain—Methotrexate—stomach cancer	0.000435	0.00121	CcSEcCtD
Danazol—Dyspepsia—Capecitabine—stomach cancer	0.000434	0.00121	CcSEcCtD
Danazol—Chills—Epirubicin—stomach cancer	0.000434	0.00121	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—stomach cancer	0.000431	0.0012	CcSEcCtD
Danazol—Alopecia—Epirubicin—stomach cancer	0.000427	0.00119	CcSEcCtD
Danazol—Fatigue—Capecitabine—stomach cancer	0.000425	0.00118	CcSEcCtD
Danazol—Vision blurred—Methotrexate—stomach cancer	0.000424	0.00118	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—stomach cancer	0.000423	0.00118	CcSEcCtD
Danazol—Constipation—Capecitabine—stomach cancer	0.000421	0.00117	CcSEcCtD
Danazol—Nausea—Fluorouracil—stomach cancer	0.000419	0.00117	CcSEcCtD
Danazol—Flushing—Doxorubicin—stomach cancer	0.000415	0.00115	CcSEcCtD
Danazol—Tension—Epirubicin—stomach cancer	0.000413	0.00115	CcSEcCtD
Danazol—Nervousness—Epirubicin—stomach cancer	0.000409	0.00114	CcSEcCtD
Danazol—Back pain—Epirubicin—stomach cancer	0.000407	0.00113	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—stomach cancer	0.000404	0.00112	CcSEcCtD
Danazol—Vertigo—Methotrexate—stomach cancer	0.000404	0.00112	CcSEcCtD
Danazol—Body temperature increased—Docetaxel—stomach cancer	0.000402	0.00112	CcSEcCtD
Danazol—Leukopenia—Methotrexate—stomach cancer	0.000402	0.00112	CcSEcCtD
Danazol—Chills—Doxorubicin—stomach cancer	0.000401	0.00112	CcSEcCtD
Danazol—Vision blurred—Epirubicin—stomach cancer	0.000396	0.0011	CcSEcCtD
Danazol—Alopecia—Doxorubicin—stomach cancer	0.000395	0.0011	CcSEcCtD
Danazol—Urticaria—Capecitabine—stomach cancer	0.000392	0.00109	CcSEcCtD
Danazol—Body temperature increased—Capecitabine—stomach cancer	0.00039	0.00108	CcSEcCtD
Danazol—Convulsion—Methotrexate—stomach cancer	0.00039	0.00108	CcSEcCtD
Danazol—Arthralgia—Methotrexate—stomach cancer	0.000383	0.00106	CcSEcCtD
Danazol—Progesterone—CYP2A6—stomach cancer	0.000382	0.136	CrCbGaD
Danazol—Tension—Doxorubicin—stomach cancer	0.000382	0.00106	CcSEcCtD
Danazol—Nervousness—Doxorubicin—stomach cancer	0.000378	0.00105	CcSEcCtD
Danazol—Vertigo—Epirubicin—stomach cancer	0.000378	0.00105	CcSEcCtD
Danazol—Syncope—Epirubicin—stomach cancer	0.000377	0.00105	CcSEcCtD
Danazol—Leukopenia—Epirubicin—stomach cancer	0.000377	0.00105	CcSEcCtD
Danazol—Back pain—Doxorubicin—stomach cancer	0.000377	0.00105	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—stomach cancer	0.000374	0.00104	CcSEcCtD
Danazol—Palpitations—Epirubicin—stomach cancer	0.000372	0.00103	CcSEcCtD
Danazol—Loss of consciousness—Epirubicin—stomach cancer	0.00037	0.00103	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—stomach cancer	0.000367	0.00102	CcSEcCtD
Danazol—Asthenia—Docetaxel—stomach cancer	0.000365	0.00102	CcSEcCtD
Danazol—Convulsion—Epirubicin—stomach cancer	0.000365	0.00101	CcSEcCtD
Danazol—Hypertension—Epirubicin—stomach cancer	0.000363	0.00101	CcSEcCtD
Danazol—Pruritus—Docetaxel—stomach cancer	0.00036	0.001	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—stomach cancer	0.000359	0.000999	CcSEcCtD
Danazol—Arthralgia—Epirubicin—stomach cancer	0.000358	0.000996	CcSEcCtD
Danazol—Anxiety—Epirubicin—stomach cancer	0.000357	0.000993	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—stomach cancer	0.000355	0.000986	CcSEcCtD
Danazol—Asthenia—Capecitabine—stomach cancer	0.000354	0.000983	CcSEcCtD
Danazol—Vertigo—Doxorubicin—stomach cancer	0.00035	0.000973	CcSEcCtD
Danazol—Syncope—Doxorubicin—stomach cancer	0.000349	0.000971	CcSEcCtD
Danazol—Pruritus—Capecitabine—stomach cancer	0.000349	0.00097	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—stomach cancer	0.000348	0.000969	CcSEcCtD
Danazol—Palpitations—Doxorubicin—stomach cancer	0.000344	0.000957	CcSEcCtD
Danazol—Oedema—Epirubicin—stomach cancer	0.000343	0.000955	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—stomach cancer	0.000342	0.000952	CcSEcCtD
Danazol—Shock—Epirubicin—stomach cancer	0.000338	0.000939	CcSEcCtD
Danazol—Convulsion—Doxorubicin—stomach cancer	0.000337	0.000938	CcSEcCtD
Danazol—Dizziness—Docetaxel—stomach cancer	0.000337	0.000936	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—stomach cancer	0.000336	0.000935	CcSEcCtD
Danazol—Hypertension—Doxorubicin—stomach cancer	0.000336	0.000935	CcSEcCtD
Danazol—Tachycardia—Epirubicin—stomach cancer	0.000335	0.000932	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000334	0.00093	CcSEcCtD
Danazol—Hyperhidrosis—Epirubicin—stomach cancer	0.000332	0.000923	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—stomach cancer	0.000331	0.000922	CcSEcCtD
Danazol—Anxiety—Doxorubicin—stomach cancer	0.00033	0.000918	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—stomach cancer	0.000329	0.000916	CcSEcCtD
Danazol—Dizziness—Capecitabine—stomach cancer	0.000326	0.000906	CcSEcCtD
Danazol—Vomiting—Docetaxel—stomach cancer	0.000324	0.0009	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—stomach cancer	0.000323	0.000898	CcSEcCtD
Danazol—Rash—Docetaxel—stomach cancer	0.000321	0.000893	CcSEcCtD
Danazol—Dermatitis—Docetaxel—stomach cancer	0.000321	0.000892	CcSEcCtD
Danazol—Headache—Docetaxel—stomach cancer	0.000319	0.000887	CcSEcCtD
Danazol—Oedema—Doxorubicin—stomach cancer	0.000318	0.000884	CcSEcCtD
Danazol—Fatigue—Methotrexate—stomach cancer	0.000316	0.00088	CcSEcCtD
Danazol—Vomiting—Capecitabine—stomach cancer	0.000313	0.000872	CcSEcCtD
Danazol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000313	0.00087	CcSEcCtD
Danazol—Shock—Doxorubicin—stomach cancer	0.000313	0.000869	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—stomach cancer	0.000311	0.000865	CcSEcCtD
Danazol—Rash—Capecitabine—stomach cancer	0.000311	0.000864	CcSEcCtD
Danazol—Dermatitis—Capecitabine—stomach cancer	0.00031	0.000863	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—stomach cancer	0.00031	0.000862	CcSEcCtD
Danazol—Headache—Capecitabine—stomach cancer	0.000309	0.000859	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—stomach cancer	0.000308	0.000857	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000307	0.000854	CcSEcCtD
Danazol—Nausea—Docetaxel—stomach cancer	0.000302	0.000841	CcSEcCtD
Danazol—Dyspepsia—Epirubicin—stomach cancer	0.000302	0.000841	CcSEcCtD
Danazol—Fatigue—Epirubicin—stomach cancer	0.000296	0.000823	CcSEcCtD
Danazol—Constipation—Epirubicin—stomach cancer	0.000294	0.000817	CcSEcCtD
Danazol—Nausea—Capecitabine—stomach cancer	0.000293	0.000814	CcSEcCtD
Danazol—Urticaria—Methotrexate—stomach cancer	0.000291	0.000811	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—stomach cancer	0.00029	0.000807	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000289	0.000805	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—stomach cancer	0.000285	0.000793	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—stomach cancer	0.00028	0.000778	CcSEcCtD
Danazol—Fatigue—Doxorubicin—stomach cancer	0.000274	0.000762	CcSEcCtD
Danazol—Urticaria—Epirubicin—stomach cancer	0.000273	0.000759	CcSEcCtD
Danazol—Constipation—Doxorubicin—stomach cancer	0.000272	0.000756	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—stomach cancer	0.000271	0.000755	CcSEcCtD
Danazol—Asthenia—Methotrexate—stomach cancer	0.000263	0.000732	CcSEcCtD
Danazol—Pruritus—Methotrexate—stomach cancer	0.00026	0.000722	CcSEcCtD
Danazol—Prednisone—ALB—stomach cancer	0.000259	0.0923	CrCbGaD
Danazol—Norethindrone—ALB—stomach cancer	0.000256	0.091	CrCbGaD
Danazol—Urticaria—Doxorubicin—stomach cancer	0.000252	0.000702	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—stomach cancer	0.000251	0.000698	CcSEcCtD
Danazol—Asthenia—Epirubicin—stomach cancer	0.000246	0.000685	CcSEcCtD
Danazol—Pruritus—Epirubicin—stomach cancer	0.000243	0.000676	CcSEcCtD
Danazol—Methyltestosterone—ALB—stomach cancer	0.000243	0.0864	CrCbGaD
Danazol—Dizziness—Methotrexate—stomach cancer	0.000243	0.000675	CcSEcCtD
Danazol—Vomiting—Methotrexate—stomach cancer	0.000233	0.000649	CcSEcCtD
Danazol—Rash—Methotrexate—stomach cancer	0.000231	0.000643	CcSEcCtD
Danazol—Dermatitis—Methotrexate—stomach cancer	0.000231	0.000643	CcSEcCtD
Danazol—Headache—Methotrexate—stomach cancer	0.00023	0.000639	CcSEcCtD
Danazol—Asthenia—Doxorubicin—stomach cancer	0.000228	0.000634	CcSEcCtD
Danazol—Dizziness—Epirubicin—stomach cancer	0.000227	0.000631	CcSEcCtD
Danazol—Pruritus—Doxorubicin—stomach cancer	0.000225	0.000625	CcSEcCtD
Danazol—Vomiting—Epirubicin—stomach cancer	0.000218	0.000607	CcSEcCtD
Danazol—Nausea—Methotrexate—stomach cancer	0.000218	0.000606	CcSEcCtD
Danazol—Rash—Epirubicin—stomach cancer	0.000216	0.000602	CcSEcCtD
Danazol—Dermatitis—Epirubicin—stomach cancer	0.000216	0.000602	CcSEcCtD
Danazol—Headache—Epirubicin—stomach cancer	0.000215	0.000598	CcSEcCtD
Danazol—Dizziness—Doxorubicin—stomach cancer	0.00021	0.000584	CcSEcCtD
Danazol—Nausea—Epirubicin—stomach cancer	0.000204	0.000567	CcSEcCtD
Danazol—Vomiting—Doxorubicin—stomach cancer	0.000202	0.000562	CcSEcCtD
Danazol—Rash—Doxorubicin—stomach cancer	0.0002	0.000557	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—stomach cancer	0.0002	0.000557	CcSEcCtD
Danazol—Headache—Doxorubicin—stomach cancer	0.000199	0.000554	CcSEcCtD
Danazol—Nausea—Doxorubicin—stomach cancer	0.000189	0.000525	CcSEcCtD
Danazol—Testosterone—ALB—stomach cancer	0.000141	0.0501	CrCbGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	5.63e-05	0.000127	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—stomach cancer	5.62e-05	0.000126	CbGpPWpGaD
Danazol—ESR1—Gene Expression—DNMT1—stomach cancer	5.6e-05	0.000126	CbGpPWpGaD
Danazol—AR—Gene Expression—PPP2R1A—stomach cancer	5.59e-05	0.000126	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CAV1—stomach cancer	5.56e-05	0.000125	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOA1—stomach cancer	5.55e-05	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—stomach cancer	5.54e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPA8—stomach cancer	5.52e-05	0.000124	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.45e-05	0.000123	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.43e-05	0.000122	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACAD8—stomach cancer	5.38e-05	0.000121	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FST—stomach cancer	5.36e-05	0.000121	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK3—stomach cancer	5.3e-05	0.000119	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTT1—stomach cancer	5.3e-05	0.000119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRKCB—stomach cancer	5.29e-05	0.000119	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HBEGF—stomach cancer	5.28e-05	0.000119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6ST—stomach cancer	5.27e-05	0.000119	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2A6—stomach cancer	5.23e-05	0.000118	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—stomach cancer	5.21e-05	0.000117	CbGpPWpGaD
Danazol—AR—Gene Expression—SMAD4—stomach cancer	5.19e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPS6—stomach cancer	5.18e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RGS2—stomach cancer	5.17e-05	0.000116	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAST—stomach cancer	5.17e-05	0.000116	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6R—stomach cancer	5.14e-05	0.000116	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKR1C3—stomach cancer	5.09e-05	0.000115	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—stomach cancer	5.07e-05	0.000114	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK1—stomach cancer	5.05e-05	0.000114	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—stomach cancer	5.05e-05	0.000114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO1—stomach cancer	4.96e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGG—stomach cancer	4.9e-05	0.00011	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.88e-05	0.00011	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB2—stomach cancer	4.87e-05	0.00011	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK3—stomach cancer	4.85e-05	0.000109	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—stomach cancer	4.82e-05	0.000108	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GMPR2—stomach cancer	4.8e-05	0.000108	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PPP2R1A—stomach cancer	4.77e-05	0.000107	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—stomach cancer	4.77e-05	0.000107	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—stomach cancer	4.74e-05	0.000107	CbGpPWpGaD
Danazol—AR—Gene Expression—ERCC2—stomach cancer	4.74e-05	0.000107	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKAA1—stomach cancer	4.72e-05	0.000106	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6R—stomach cancer	4.7e-05	0.000106	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RHOA—stomach cancer	4.65e-05	0.000105	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK1—stomach cancer	4.62e-05	0.000104	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—stomach cancer	4.62e-05	0.000104	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—stomach cancer	4.6e-05	0.000103	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RBP4—stomach cancer	4.56e-05	0.000103	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMAD4—stomach cancer	4.43e-05	9.97e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—stomach cancer	4.41e-05	9.92e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—stomach cancer	4.4e-05	9.91e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD44—stomach cancer	4.4e-05	9.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—IDH3B—stomach cancer	4.39e-05	9.88e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.39e-05	9.88e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—stomach cancer	4.38e-05	9.85e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—stomach cancer	4.36e-05	9.81e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPP2R1A—stomach cancer	4.31e-05	9.69e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB2—stomach cancer	4.3e-05	9.68e-05	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—stomach cancer	4.28e-05	9.62e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—stomach cancer	4.27e-05	9.61e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.27e-05	9.61e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RHOA—stomach cancer	4.25e-05	9.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FYN—stomach cancer	4.21e-05	9.47e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—stomach cancer	4.21e-05	9.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.08e-05	9.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.08e-05	9.18e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—stomach cancer	4.08e-05	9.18e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—stomach cancer	4.05e-05	9.12e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—stomach cancer	4.01e-05	9.01e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SMAD4—stomach cancer	4e-05	9e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1B—stomach cancer	3.98e-05	8.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGFR2—stomach cancer	3.95e-05	8.89e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—stomach cancer	3.93e-05	8.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGTR2—stomach cancer	3.92e-05	8.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HSPB1—stomach cancer	3.92e-05	8.82e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—stomach cancer	3.88e-05	8.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—F2R—stomach cancer	3.87e-05	8.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BMP2—stomach cancer	3.87e-05	8.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKR1C3—stomach cancer	3.81e-05	8.58e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—stomach cancer	3.8e-05	8.55e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—stomach cancer	3.79e-05	8.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR1A—stomach cancer	3.77e-05	8.49e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPP2R1A—stomach cancer	3.74e-05	8.42e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—stomach cancer	3.73e-05	8.39e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—stomach cancer	3.71e-05	8.34e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—stomach cancer	3.69e-05	8.3e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—stomach cancer	3.68e-05	8.27e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—stomach cancer	3.67e-05	8.26e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ERCC2—stomach cancer	3.65e-05	8.21e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1B—stomach cancer	3.64e-05	8.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ANXA1—stomach cancer	3.64e-05	8.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PGLS—stomach cancer	3.64e-05	8.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BLVRB—stomach cancer	3.64e-05	8.18e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—stomach cancer	3.62e-05	8.14e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS2—stomach cancer	3.62e-05	8.14e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—stomach cancer	3.61e-05	8.13e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—stomach cancer	3.59e-05	8.07e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—stomach cancer	3.55e-05	7.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB1—stomach cancer	3.53e-05	7.94e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CAV1—stomach cancer	3.51e-05	7.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOA1—stomach cancer	3.5e-05	7.87e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—stomach cancer	3.48e-05	7.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.47e-05	7.81e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—stomach cancer	3.47e-05	7.8e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—stomach cancer	3.41e-05	7.68e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—stomach cancer	3.37e-05	7.59e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—stomach cancer	3.37e-05	7.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RPS6—stomach cancer	3.37e-05	7.58e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—stomach cancer	3.36e-05	7.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCB—stomach cancer	3.34e-05	7.51e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6ST—stomach cancer	3.32e-05	7.48e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—stomach cancer	3.31e-05	7.45e-05	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—stomach cancer	3.3e-05	7.41e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—stomach cancer	3.28e-05	7.38e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—stomach cancer	3.28e-05	7.38e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—stomach cancer	3.25e-05	7.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—stomach cancer	3.19e-05	7.19e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ERCC2—stomach cancer	3.17e-05	7.13e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK3—stomach cancer	3.13e-05	7.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HBEGF—stomach cancer	3.1e-05	6.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FBP1—stomach cancer	3.09e-05	6.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.09e-05	6.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA1—stomach cancer	3.09e-05	6.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CKB—stomach cancer	3.09e-05	6.96e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—stomach cancer	3.05e-05	6.86e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—stomach cancer	3.03e-05	6.82e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—stomach cancer	3e-05	6.75e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK1—stomach cancer	2.98e-05	6.71e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—stomach cancer	2.98e-05	6.71e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—stomach cancer	2.98e-05	6.71e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6R—stomach cancer	2.97e-05	6.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLIN2—stomach cancer	2.91e-05	6.54e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK3—stomach cancer	2.87e-05	6.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—stomach cancer	2.86e-05	6.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA2—stomach cancer	2.83e-05	6.36e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—stomach cancer	2.82e-05	6.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP2R1A—stomach cancer	2.8e-05	6.3e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—stomach cancer	2.79e-05	6.27e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—stomach cancer	2.78e-05	6.26e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK3—stomach cancer	2.78e-05	6.25e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—stomach cancer	2.78e-05	6.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PGAM1—stomach cancer	2.76e-05	6.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NT5E—stomach cancer	2.76e-05	6.2e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAV1—stomach cancer	2.75e-05	6.19e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOA1—stomach cancer	2.74e-05	6.17e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK1—stomach cancer	2.73e-05	6.13e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—stomach cancer	2.73e-05	6.13e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—stomach cancer	2.7e-05	6.08e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RHOA—stomach cancer	2.68e-05	6.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—stomach cancer	2.65e-05	5.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.63e-05	5.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCE1—stomach cancer	2.63e-05	5.92e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.63e-05	5.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMAD4—stomach cancer	2.6e-05	5.85e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—stomach cancer	2.59e-05	5.82e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—stomach cancer	2.58e-05	5.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UMPS—stomach cancer	2.52e-05	5.67e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—stomach cancer	2.51e-05	5.64e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—stomach cancer	2.5e-05	5.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—stomach cancer	2.48e-05	5.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FYN—stomach cancer	2.47e-05	5.56e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—stomach cancer	2.42e-05	5.44e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—stomach cancer	2.39e-05	5.39e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—stomach cancer	2.37e-05	5.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—stomach cancer	2.35e-05	5.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PDHA1—stomach cancer	2.34e-05	5.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ECHS1—stomach cancer	2.34e-05	5.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR2—stomach cancer	2.32e-05	5.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—stomach cancer	2.3e-05	5.17e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—stomach cancer	2.29e-05	5.15e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—stomach cancer	2.29e-05	5.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMP—stomach cancer	2.2e-05	4.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FADS1—stomach cancer	2.2e-05	4.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—stomach cancer	2.19e-05	4.93e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—stomach cancer	2.19e-05	4.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—stomach cancer	2.19e-05	4.92e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—stomach cancer	2.17e-05	4.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—stomach cancer	2.13e-05	4.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS2—stomach cancer	2.12e-05	4.78e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—stomach cancer	2.12e-05	4.77e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK3—stomach cancer	2.12e-05	4.76e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—stomach cancer	2.1e-05	4.71e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—stomach cancer	2.08e-05	4.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—stomach cancer	2.07e-05	4.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SREBF2—stomach cancer	2.06e-05	4.64e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—stomach cancer	2.06e-05	4.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CAV1—stomach cancer	2.06e-05	4.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOA1—stomach cancer	2.05e-05	4.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RORA—stomach cancer	2.04e-05	4.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCB—stomach cancer	1.96e-05	4.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6ST—stomach cancer	1.95e-05	4.39e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDOB—stomach cancer	1.91e-05	4.3e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—stomach cancer	1.91e-05	4.3e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—stomach cancer	1.9e-05	4.28e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—stomach cancer	1.89e-05	4.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—stomach cancer	1.87e-05	4.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK3—stomach cancer	1.81e-05	4.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALOX5—stomach cancer	1.78e-05	4e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—stomach cancer	1.76e-05	3.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DPYD—stomach cancer	1.75e-05	3.93e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6R—stomach cancer	1.74e-05	3.92e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK1—stomach cancer	1.72e-05	3.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—stomach cancer	1.72e-05	3.87e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK3—stomach cancer	1.63e-05	3.67e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—stomach cancer	1.63e-05	3.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—stomach cancer	1.62e-05	3.65e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—stomach cancer	1.59e-05	3.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RHOA—stomach cancer	1.57e-05	3.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—stomach cancer	1.56e-05	3.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—stomach cancer	1.55e-05	3.48e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.53e-05	3.44e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—stomach cancer	1.49e-05	3.36e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.49e-05	3.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—stomach cancer	1.46e-05	3.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO1—stomach cancer	1.45e-05	3.26e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—stomach cancer	1.44e-05	3.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—stomach cancer	1.38e-05	3.11e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—stomach cancer	1.38e-05	3.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—stomach cancer	1.35e-05	3.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—stomach cancer	1.32e-05	2.97e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—stomach cancer	1.29e-05	2.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD44—stomach cancer	1.28e-05	2.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—stomach cancer	1.28e-05	2.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—stomach cancer	1.25e-05	2.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—stomach cancer	1.24e-05	2.8e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—stomach cancer	1.21e-05	2.73e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—stomach cancer	1.17e-05	2.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—stomach cancer	1.12e-05	2.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—stomach cancer	1.11e-05	2.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.09e-05	2.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—stomach cancer	1.07e-05	2.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK3—stomach cancer	1.06e-05	2.39e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—stomach cancer	1.06e-05	2.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—stomach cancer	1.03e-05	2.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK1—stomach cancer	1.01e-05	2.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—stomach cancer	1.01e-05	2.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—stomach cancer	9.96e-06	2.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—stomach cancer	9.84e-06	2.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—stomach cancer	9.53e-06	2.14e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ERCC2—stomach cancer	9.25e-06	2.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—stomach cancer	8.76e-06	1.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—stomach cancer	8.7e-06	1.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—stomach cancer	8.47e-06	1.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—stomach cancer	8.1e-06	1.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAV1—stomach cancer	8.02e-06	1.81e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOA1—stomach cancer	8.01e-06	1.8e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—stomach cancer	7.76e-06	1.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—stomach cancer	7.05e-06	1.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—stomach cancer	6.34e-06	1.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—stomach cancer	6.07e-06	1.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—stomach cancer	5.55e-06	1.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.41e-06	7.68e-06	CbGpPWpGaD
